Methods for the early diagnosis of ovarian cancer
OwnerTimothy J. O'Brieninventor
Life of this patent
Estimating the term…
Abstract
The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. Specifically, the present invention relates to expression of PUMP-1 protease (matrix metalloprotease 7). The detected proteases are themselves specifically over-expressed in certain cancers, and their presence may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.
Claims2
An immunogenic composition, comprising a fragment of a matrix metalloprotease 7 protein encoded by nucleotide sequence SEQ ID NO:
- 29 and an appropriate adjuvant, wherein said fragment consist of 9 amino acids.
Dependencies are inferred from the claim text.